Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY24.45 CNY
Change Today -1.47 / -5.67%
Volume 50.3M
600572 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang conba pharmaceuti-a (600572) Snapshot

Open
CNY24.50
Previous Close
CNY25.92
Day High
CNY27.34
Day Low
CNY23.33
52 Week High
06/9/15 - CNY33.63
52 Week Low
07/18/14 - CNY14.24
Market Cap
24.1B
Average Volume 10 Days
34.3M
EPS TTM
CNY0.66
Shares Outstanding
984.6M
EX-Date
07/7/15
P/E TM
37.2x
Dividend
CNY0.17
Dividend Yield
0.65%
Current Stock Chart for ZHEJIANG CONBA PHARMACEUTI-A (600572)

Related News

No related news articles were found.

zhejiang conba pharmaceuti-a (600572) Related Businessweek News

No Related Businessweek News Found

zhejiang conba pharmaceuti-a (600572) Details

Zhejiang Conba Pharmaceutical Co., Ltd. operates as a pharmaceutical company in the People’s Republic of China. It provides traditional Chinese medicines, botanical extracts, chemical medicines, chemical raw medicines, health foods, common foods, prepared drugs in pieces, and commodities. The company offers its products under the Conba, Prostate Plus, Zhenshiming, Prostate Plus, Tianbaoning, Alocin, Xitao, Yuanbang, Baby, Omeprazole, etc. brands. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang Conba Pharmaceutical Co., Ltd. in October 1999. Zhejiang Conba Pharmaceutical Co., Ltd. was founded in 1969 and is headquartered in Hangzhou, the People’s Republic of China.

Founded in 1969

zhejiang conba pharmaceuti-a (600572) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang conba pharmaceuti-a (600572) Key Developments

Zhejiang Conba Pharmaceutical Co., Ltd. Declares 2014 Profit Distribution, Payable on July 7, 2015

Zhejiang Conba Pharmaceutical Co.,Ltd. announced profit distribution and capitalization from capital public reserve in 2014 as RMB 0.17 (taxes included) for each share. Record date is July 6, 2015 and ex-right and ex-dividend date is July 7, 2015. Cash dividend payable on July 7, 2015.

Zhejiang Conba Pharmaceutical Co.,Ltd., Board Meeting, May 27, 2015

Zhejiang Conba Pharmaceutical Co.,Ltd., Board Meeting, May 27, 2015. Agenda: To discuss and approve the 'proposal of the scheme on significant assets purchase'; to consider the 'proposal of 'report (draft) on significant assets purchase' and its abstract'; and to consider the 'proposal of signing relevant agreements with collateral entry-into-force conditions with transaction party of significant assets purchase.

Zhejiang Conba Pharmaceutical Co.,Ltd., Special/Extraordinary Shareholders Meeting, Jun 12, 2015

Zhejiang Conba Pharmaceutical Co.,Ltd., Special/Extraordinary Shareholders Meeting, Jun 12, 2015. Agenda: To discuss the proposal of the scheme on significant assets purchase; to consider the proposal of 'report (draft) on significant assets purchase' and its abstract; and to consider the proposal of signing relevant agreements with collateral entry-into-force conditions with transaction party of significant assets purchase.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600572:CH CNY24.45 CNY -1.47

600572 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600572.
View Industry Companies
 

Industry Analysis

600572

Industry Average

Valuation 600572 Industry Range
Price/Earnings 36.8x
Price/Sales 5.4x
Price/Book 7.0x
Price/Cash Flow 44.5x
TEV/Sales 5.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG CONBA PHARMACEUTI-A, please visit www.conba.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.